Omega-3 + D3 + K2: The Science Behind the Triple Stack
Vitamin D3 helps your body absorb calcium. Vitamin K2 directs that calcium into bones and teeth instead of arteries and soft tissue. Omega-3 provides the fat needed for both fat-soluble vitamins to absorb properly. This three-nutrient stack addresses a real metabolic gap — and it is especially relevant if you live in Northern Europe.
Who This Is For
Adults concerned about bone density, cardiovascular health, or anyone already taking vitamin D who wants to make sure calcium goes where it should. After reading, you will understand the D3-K2 partnership, know exact doses, and be able to choose between combo and separate products.
TL;DR
- Vitamin D3 increases calcium absorption from the gut by up to 40% (Holick, 2007)
- Without K2, that extra calcium can deposit in arteries instead of bones — K2 activates proteins that redirect it (Schurgers et al., 2007)
- Omega-3 fish oil serves as a fat-soluble vitamin carrier, boosting absorption of both D3 and K2
- Recommended daily: 1,000–2,000 IU D3 + 100–200 mcg K2 (MK-7 form) + 1,000 mg EPA/DHA
- The MK-7 form of K2 has a longer half-life (72 hours) than MK-4 (1–2 hours), making once-daily dosing effective
- This stack is particularly valuable for post-menopausal women and men over 50
The Calcium Paradox: Why D3 Alone Is Not Enough
Here is the problem. Vitamin D3 is excellent at pulling calcium from your food into your bloodstream. The European Food Safety Authority recognizes D3's contribution to normal calcium absorption and bone maintenance (EFSA, 2010). But once calcium is in the blood, your body needs instructions on where to put it.
Without adequate vitamin K2, calcium can accumulate in arterial walls. This process — called vascular calcification — is a recognized cardiovascular risk factor (Demer & Tintut, 2008). The Rotterdam Study, following 4,807 subjects over 7–10 years, found that individuals with the highest dietary vitamin K2 intake had a 57% lower risk of coronary heart disease mortality and a 52% lower risk of aortic calcification (Geleijnse et al., 2004).
This does not mean vitamin D causes arterial calcification. It means that vitamin D without K2 creates a mismatch: more calcium absorption without enough directional control.
How the Three Nutrients Work Together
Vitamin D3: The Absorber
D3 (cholecalciferol) is converted in the liver to 25(OH)D and then in the kidneys to the active form 1,25(OH)2D. This active form upregulates calcium-binding proteins in the intestine, increasing calcium absorption from a baseline of about 10–15% to as much as 40% (Holick, 2007).
Vitamin K2: The Traffic Director
K2 activates two critical proteins:
1. Osteocalcin — produced by osteoblasts (bone-building cells). In its uncarboxylated (inactive) form, osteocalcin cannot bind calcium. K2 carboxylates it, enabling it to lock calcium into the bone matrix (Hauschka et al., 1989).
2. Matrix GLA protein (MGP) — the body's most potent inhibitor of vascular calcification. Without K2, MGP remains inactive, and calcium freely deposits in arterial walls (Schurgers et al., 2007).
The clinical evidence is substantial. Knapen et al. (2013) conducted a 3-year randomized controlled trial with 244 post-menopausal women, finding that 180 mcg/day of MK-7 significantly improved bone mineral content and bone strength, while also preserving arterial flexibility.
Omega-3: The Absorption Vehicle
Both D3 and K2 are fat-soluble vitamins. Taking them without fat reduces absorption significantly. A study by Dawson-Hughes et al. (2015) showed that vitamin D absorbed with fat increased serum levels by roughly 32% compared to taking it without fat. The 1,000 mg of fish oil in a standard omega-3 capsule provides an ideal fat matrix.
Beyond serving as a carrier, omega-3 EPA and DHA independently support cardiovascular health by reducing triglycerides (Mozaffarian & Wu, 2011) and bone health by reducing osteoclast activity (Watkins et al., 2003).
Dosing: How Much of Each
| Nutrient | Daily dose | Form | Key notes |
|---|---|---|---|
| Vitamin D3 | 1,000–2,000 IU | Cholecalciferol | Up to 4,000 IU safe (EFSA, 2012) |
| Vitamin K2 | 100–200 mcg | MK-7 (menaquinone-7) | MK-7 preferred over MK-4 for half-life |
| EPA + DHA | 1,000–2,000 mg | Triglyceride form | Check per-capsule, not per-serving |
Why MK-7, Not MK-4?
Vitamin K2 comes in several subtypes. MK-4 (menatetrenone) has a half-life of only 1–2 hours and requires multiple daily doses (typically 15 mg, three times per day) to maintain blood levels. MK-7 (menaquinone-7, derived from natto fermentation) has a half-life of approximately 72 hours, making a single daily dose of 100–200 mcg effective (Schurgers et al., 2007).
Most clinical trials showing bone and cardiovascular benefits have used MK-7 at 90–360 mcg/day (Knapen et al., 2013; Knapen et al., 2015).
Step-by-Step: Building Your Stack
1. Start with a vitamin D blood test. Get 25(OH)D measured (€15–25 at Synlab or Medicumi in Estonia). Target: 75–125 nmol/L.
2. If D3 deficient (<50 nmol/L): Begin with 2,000–4,000 IU D3/day for 8–12 weeks to correct, then drop to 1,000–2,000 IU for maintenance.
3. Add K2 from day one. There is no need to wait. 100–200 mcg MK-7 daily ensures calcium goes to bones from the start.
4. Choose your omega-3. At least 1,000 mg combined EPA+DHA per day. Take all three nutrients with your largest fat-containing meal.
5. Retest D3 levels after 3 months. Adjust D3 dose based on results. K2 and omega-3 doses remain stable.
Product Formats Compared
| Format | Pros | Cons | Best for |
|---|---|---|---|
| Triple combo (D3+K2+omega-3 in one capsule) | One product, simplest routine | Fixed ratios, lower D3 doses typical | Maintenance when D3 is already adequate |
| D3+K2 combo + separate omega-3 | Flexible D3/K2 dosing, good omega-3 control | Two products to buy | Most people |
| All three separate | Maximum dose control | Three products, more expensive | Correcting deficiency, athletes |
Who Should Be Careful
- People on warfarin/coumadin: Vitamin K2 can interfere with these blood-thinning medications by affecting clotting factors. Consult your physician before adding K2. Omega-3 and D3 are generally compatible with warfarin at standard doses (Booth, 2012).
- People with kidney disease: Impaired vitamin D metabolism requires medical supervision for dosing.
- Those on calcium supplements: If you already take calcium pills plus D3, adding K2 is arguably even more important to direct that calcium appropriately.
Common Mistakes
1. Taking D3 without K2. The more vitamin D you take, the more calcium your body absorbs, and the more K2 you need to direct it. This is the single most important takeaway.
2. Choosing MK-4 over MK-7. MK-4 requires much higher doses taken multiple times per day. MK-7 works with one daily dose.
3. Ignoring the fat requirement. All three nutrients need dietary fat for absorption. Take with a real meal, not just a glass of water.
4. Buying products with only D3 and K2 in a dry tablet. Oil-based softgels deliver fat-soluble vitamins more effectively. If using tablets, take them with omega-3 capsules or food containing fat.
5. Mega-dosing K2 to "catch up." K2 does not need loading doses. 100–200 mcg/day reaches effective levels within 2–3 weeks.
FAQ
Can vitamin K2 cause blood clots?
No. This is a common confusion between K1 and K2. Vitamin K1 is the primary driver of blood clotting. K2 at supplemental doses (100–200 mcg/day) does not increase clotting risk in healthy people. However, if you take warfarin, K2 can interfere with the drug's mechanism — consult your doctor (Booth, 2012).
Do I need this stack if I eat dairy and fish regularly?
Dairy provides some K2 (especially from grass-fed sources), and fatty fish provides D3 and omega-3. However, even regular fish eaters in Northern Europe rarely reach optimal D3 levels in winter without supplementation (Webb et al., 1988). K2 intake from food alone is typically well below the 100 mcg threshold shown to benefit bones in clinical trials (Beulens et al., 2009).
How long before I see results for bone density?
Bone is slow tissue. The Knapen et al. (2013) trial showed measurable improvements in bone mineral content after 3 years of 180 mcg MK-7 supplementation. However, reductions in uncarboxylated osteocalcin (a marker of K2 activity) appear within weeks, and arterial stiffness improvements can be measured within 3–6 months.
Is it safe to take D3+K2 in summer too?
Yes. Even in summer, most Northern Europeans who work indoors do not produce enough vitamin D from sunlight alone. You can reduce the D3 dose (e.g., 600–1,000 IU) during sunny months, but K2 and omega-3 doses should remain constant year-round (Cashman et al., 2016).
What about vitamin K2 and bone health in men?
Most K2 research focuses on post-menopausal women because they face the highest osteoporosis risk. However, men also lose bone density with age, and the mechanisms (osteocalcin activation, MGP carboxylation) are identical. There is no biological reason to exclude men from this stack (Kanellakis et al., 2012).
Estonia-Specific Considerations
Osteoporosis-related fractures are a significant health burden in Estonia, particularly among women over 65. The Estonian Osteoporosis Foundation recommends vitamin D supplementation, but K2 is not yet part of standard guidelines — making it an underutilized addition.
D3+K2 combo products are available in Estonian pharmacies (Apotheka, Südameapteek) in the €10–18 range for a month's supply. Triple-stack products (D3+K2+omega-3 in one capsule) are less common in physical stores but available online at MaxFit.ee with broader brand selection.
Blood testing for vitamin D (25-OH-D) is straightforward at €15–25 through Synlab or Medicumi without a doctor's referral. There is no routine test for K2 status, but uncarboxylated osteocalcin (ucOC) can be measured as a proxy — though this is mainly relevant for research purposes.
References
1. Holick, M.F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281.
2. Schurgers, L.J., Teunissen, K.J.F., Hamulyak, K., Knapen, M.H.J., Vik, H. & Vermeer, C. (2007). Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood, 109(8), 3279–3283.
3. Geleijnse, J.M., Vermeer, C., Grobbee, D.E. et al. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. Journal of Nutrition, 134(11), 3100–3105.
4. Demer, L.L. & Tintut, Y. (2008). Vascular calcification: pathobiology of a multifaceted disease. Circulation, 117(22), 2938–2948.
5. Knapen, M.H.J., Drummen, N.E., Smit, E., Vermeer, C. & Theuwissen, E. (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International, 24(9), 2499–2507.
6. Hauschka, P.V., Lian, J.B., Cole, D.E.C. & Gundberg, C.M. (1989). Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiological Reviews, 69(3), 990–1047.
7. Dawson-Hughes, B., Harris, S.S., Lichtenstein, A.H., Dolnikowski, G., Palermo, N.J. & Rasmussen, H. (2015). Dietary fat increases vitamin D-3 absorption. Journal of the Academy of Nutrition and Dietetics, 115(2), 225–230.
8. Mozaffarian, D. & Wu, J.H.Y. (2011). Omega-3 fatty acids and cardiovascular disease. Journal of the American College of Cardiology, 58(20), 2047–2067.
9. Watkins, B.A., Li, Y., Lippman, H.E. & Seifert, M.F. (2003). Omega-3 polyunsaturated fatty acids and skeletal health. Experimental Biology and Medicine, 228(9), 1011–1020.
10. EFSA Panel on Dietetic Products, Nutrition and Allergies. (2010). Scientific opinion on the substantiation of health claims related to vitamin D. EFSA Journal, 8(2), 1468.
11. EFSA Panel on Dietetic Products, Nutrition and Allergies. (2012). Scientific opinion on the tolerable upper intake level of vitamin D. EFSA Journal, 10(7), 2813.
12. Booth, S.L. (2012). Vitamin K: food composition and dietary intakes. Food and Nutrition Research, 56, 5505.
13. Knapen, M.H.J., Braam, L.A.J.L.M., Drummen, N.E., Bekers, O., Hoeks, A.P.G. & Vermeer, C. (2015). Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thrombosis and Haemostasis, 113(5), 1135–1144.
14. Webb, A.R., Kline, L. & Holick, M.F. (1988). Influence of season and latitude on the cutaneous synthesis of vitamin D3. Journal of Clinical Endocrinology and Metabolism, 67(2), 373–378.
15. Cashman, K.D., Dowling, K.G., Skrabakova, Z. et al. (2016). Vitamin D deficiency in Europe: pandemic? American Journal of Clinical Nutrition, 103(4), 1033–1044.
16. Beulens, J.W.J., Bots, M.L., Atsma, F. et al. (2009). High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis, 203(2), 489–493.
17. Kanellakis, S., Moschonis, G., Tenta, R. et al. (2012). Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and vitamin K1. Calcified Tissue International, 90(2), 76–86.
See also:
- Vitamiin D 25 Oh: Complete Guide 2026
- Vitamiini Puuduse Test — What You Need to Know
- Cholecalciferol (Vitamin D3): A Dosage and Form Guide for Northern Climates
---
Browse D3+K2 and omega-3 products at MaxFit.ee →
See also:
